Q4 EPS Estimate for Tenet Healthcare Lowered by Analyst

Tenet Healthcare Co. (NYSE:THC) – Analysts at Zacks Research lowered their Q4 2024 earnings estimates for Tenet Healthcare in a research note issued on Wednesday, December 18th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $2.87 per share for the quarter, down from their previous forecast of $2.88. The consensus estimate for Tenet Healthcare’s current full-year earnings is $11.38 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q2 2025 earnings at $2.66 EPS, Q4 2025 earnings at $3.20 EPS and Q1 2026 earnings at $3.45 EPS.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Tuesday, October 29th. The company reported $2.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.33 by $0.60. Tenet Healthcare had a net margin of 14.91% and a return on equity of 24.05%. The company had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.05 billion. During the same period in the previous year, the firm posted $1.44 EPS. The firm’s revenue was up 1.1% compared to the same quarter last year.

Several other equities analysts have also issued reports on the company. JPMorgan Chase & Co. restated an “overweight” rating and set a $175.00 price target on shares of Tenet Healthcare in a research report on Tuesday, December 17th. Wells Fargo & Company downgraded shares of Tenet Healthcare from an “overweight” rating to an “equal weight” rating and reduced their target price for the stock from $205.00 to $150.00 in a research report on Monday, November 25th. Cantor Fitzgerald boosted their price objective on shares of Tenet Healthcare from $168.00 to $177.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 30th. Barclays raised their target price on shares of Tenet Healthcare from $171.00 to $190.00 and gave the company an “overweight” rating in a research note on Friday, November 8th. Finally, UBS Group upped their price target on Tenet Healthcare from $197.00 to $217.00 and gave the stock a “buy” rating in a research note on Wednesday, October 30th. Three analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $166.88.

Tenet Healthcare Stock Up 0.1 %

Shares of THC opened at $129.71 on Monday. The firm has a market cap of $12.34 billion, a P/E ratio of 4.16, a P/E/G ratio of 0.61 and a beta of 2.06. The company has a debt-to-equity ratio of 2.35, a current ratio of 1.58 and a quick ratio of 1.52. Tenet Healthcare has a 1 year low of $73.21 and a 1 year high of $171.20. The stock has a 50 day simple moving average of $148.61 and a two-hundred day simple moving average of $149.17.

Institutional Investors Weigh In On Tenet Healthcare

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Innealta Capital LLC bought a new stake in Tenet Healthcare during the 2nd quarter valued at approximately $28,000. Plato Investment Management Ltd purchased a new position in Tenet Healthcare in the third quarter worth about $28,000. ORG Wealth Partners LLC bought a new position in shares of Tenet Healthcare during the 3rd quarter valued at approximately $30,000. Blue Trust Inc. raised its stake in shares of Tenet Healthcare by 93.0% in the second quarter. Blue Trust Inc. now owns 249 shares of the company’s stock valued at $33,000 after acquiring an additional 120 shares during the period. Finally, Kayne Anderson Rudnick Investment Management LLC purchased a new position in Tenet Healthcare during the 2nd quarter valued at $34,000. Institutional investors own 95.44% of the company’s stock.

Insider Activity

In other news, EVP Lisa Y. Foo sold 4,000 shares of Tenet Healthcare stock in a transaction on Thursday, October 31st. The shares were sold at an average price of $155.94, for a total transaction of $623,760.00. Following the transaction, the executive vice president now owns 15,566 shares in the company, valued at $2,427,362.04. This trade represents a 20.44 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 0.93% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.